Rash News and Research

RSS

Targeted drug zongertinib shows strong results for HER2-mutant lung cancer in clinical trial

The HER2-targeted therapy zongertinib demonstrated clinical benefits for previously treated patients with advanced HER2-mutant non-small cell lung cancer – particularly those with specific HER2 mutations – with manageable side effects, according to results from the Phase Ia/Ib Beamion LUNG-1 trial led by researchers from The University of Texas MD Anderson Cancer Center.

28 Apr 2025

New topical gel reduces painful rash from colorectal cancer treatment

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients undergoing anti-EGFR therapies for colorectal cancer.

28 Apr 2025

Why measles is back in the U.S. and what doctors must know now

Measles is making a troubling comeback in the U.S., driven by declining vaccination rates and rising vaccine hesitancy. Pediatric infectious disease experts provide clinical guidance to help healthcare providers recognize, manage, and prevent measles in today’s outbreak-prone environment.

14 Apr 2025

What really causes keto flu, and how can you prevent it?

A scoping review from the University of Bergen identifies a wide range of transient symptoms—collectively known as "keto flu"—that occur during the initiation of a ketogenic diet. The review explores their physiological basis and highlights strategies, such as MCTs and electrolyte supplementation, to ease the transition.

13 Apr 2025

Mpox virus poses rising global epidemic and pandemic threat

Insufficient research on mpox hinders effective control strategies, emphasizing the need to understand its transmission and immune response mechanisms.

7 Apr 2025

Shingles vaccine cuts dementia risk by 20%, new study shows

A large natural experiment shows that the herpes zoster vaccine reduces dementia diagnoses by 20% over seven years. The findings suggest both viral suppression and immune training may play roles in brain health.

3 Apr 2025

Research highlights rising risk of human-to-human mpox transmission

Mpox has the potential to become a significant global health threat if taken too lightly, according to scientists at the University of Surrey.

1 Apr 2025

UTA expert discusses the latest developments of measles outbreak in Texas

Measles is a highly contagious disease that was declared eliminated from the U.S. by the World Health Organization 25 years ago due to the success of vaccination efforts.

28 Mar 2025

Study points to single respiratory virus as cause of Kawasaki disease

Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly suggests that Kawasaki disease is caused by a single respiratory virus that is yet to be identified.

27 Mar 2025

CDC confirms black-legged ticks can cause red meat allergy in humans

Researchers confirmed that black-legged ticks (Ixodes scapularis) can trigger alpha-gal syndrome in humans. A 10-year surveillance in Maine identified 23 confirmed cases of the meat allergy outside the lone star tick’s known range.

23 Mar 2025

Case study: Bartonella, Babesia pathogens can be a cofactor in complex neurological illnesses

In a new case study, researchers from North Carolina State University found Bartonella henselae, Babesia odocoilei and Babesia divergens-like MO-1 DNA in brain tissue samples from a young child with seizures and suspected Rasmussen's encephalitis.

22 Mar 2025

Oropouche virus: Emerging threats, symptoms, and prevention

Researchers provide an overview of the emerging Oropouche virus.

19 Mar 2025

New treatment option for advanced thymic carcinoma shows promise

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma.

12 Mar 2025

Measles cases surge in Europe amid vaccine gaps

Data presented in the monthly measles and rubella update by the European Centre for Disease Prevention and Control (ECDC) indicate ongoing transmission of measles across a number of countries in EU/EEA, with a steep rise in cases reported during 2024.

11 Mar 2025

Venom is everywhere: Study examines hidden toxin delivery systems across life forms

Forget snakes and spiders—a new review details venomous plants, fungi, and even bacteria, proving that nature's deadliest secret weapon is more widespread than we ever imagined.

23 Feb 2025

New clinical trial seeks alternatives for head and neck cancer patients unable to use cisplatin

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug cisplatin.

21 Feb 2025

Vimseltinib gains FDA approval for treating tenosynovial giant cell tumor

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that lines the joints.

20 Feb 2025

Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for adults with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy, irrespective of PD-L1 expression level or tumor histology.

14 Feb 2025

NIH clinical trial examines investigational therapy for dengue

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

11 Feb 2025

NIH-supported clinical trial to test experimental treatment for dengue

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

31 Jan 2025